Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Mallinckrodt
Moodys
Colorcon
Baxter

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Virtus Pharms Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for VIRTUS PHARMS, and what generic and branded alternatives to VIRTUS PHARMS drugs are available?

VIRTUS PHARMS has fifteen approved drugs.



Summary for Virtus Pharms
US Patents:0
Tradenames:8
Ingredients:8
NDAs:15

Drugs and US Patents for Virtus Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Virtus Pharms PROMETRIUM progesterone CAPSULE;ORAL 019781-003 Oct 15, 1999 DISCN No No   Start Trial   Start Trial
Virtus Pharms PHENDIMETRAZINE TARTRATE phendimetrazine tartrate CAPSULE, EXTENDED RELEASE;ORAL 018074-001 Approved Prior to Jan 1, 1982 RX Yes Yes   Start Trial   Start Trial
Virtus Pharms LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 091291-001 Sep 12, 2011 DISCN No No   Start Trial   Start Trial
Virtus Pharms PHENDIMETRAZINE TARTRATE phendimetrazine tartrate CAPSULE;ORAL 085695-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
McKinsey
Medtronic
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.